EP. 10 Counseling Patients with Multiple Myeloma on the Infection Risks of BCMA-Targeting Bispecifics
EP. 12 Advice for Patients, Nurse Practitioners, and Community Oncologists on Teclistamab Therapy in Multiple Myeloma
November 4th, 2026CD38-Targeted Immuno-PET Helps Detect Active Multiple MyelomaIn a phase 2 trial, CD38-targeted immune-PET detected active multiple myeloma in some patients with no signs of disease on standard fluorodeoxyglucose PET/CT.Read more
October 29th, 2026Can a Selinexor Quadruplet Treat Myeloma After T-Cell Redirecting Therapy? “If it is successful, you should be able to access this combination wherever you are,” said Natalie S. Callander, MD, of the UW Carbone Cancer Center.Read more